Expansion of hematopoietic progenitor cells (HPC) in the presence of endothelium has been shown to result in grafts capable of restoring hematopoiesis in a myeloablated host. However, the use of xenogeneic endothelium or cell lines may carry risks in a clinical transplantation setting. We explored the feasibility of cord blood progenitor cell expansion in vitro in an autologous coculture system using umbilical vein endothelial cells (HUVEC). CD34 þ HPC and HUVEC were isolated from the same umbilical cord. For 3 days, HPC were maintained in serum-free medium supplemented with a single cytokine (SCF) or a cytokine combination (SCF, Flt3-ligand, IL-6). Meanwhile, adherent HUVEC cultures were established. After addition of VEGF and IL-1 at day 3, the cells were either added to HUVEC cultures or grown without endothelial cells for further 7 days. Total cells, CD34 þ and clonogenic progenitors were significantly increased when coculture was compared to liquid culture. Long-term cultureinitiating cells (LTC-IC) and cobble stone area-forming cells (CAFC, limiting dilution analysis) were detected more frequently after coculture with endothelial cells. Also precursors and mature myeloid cells were observed after expansion. We conclude that coculture with autologous HUVEC represents a feasable approach for ex vivo expansion of cord blood HPC. Bone Marrow Transplantation (2005) 36, 71-79.
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In the hematopoietic microenvironment, endothelial cells play an important role in the regulation of hematopoietic cell proliferation and trafficking.
1,2 Secretion of hematopoietic cytokines by endothelial cells and direct cellular contact, which allows interaction of adhesion molecules and surface-bound cytokines or chemokines with their corresponding receptors, may contribute to maintenance of progenitor and stem cells (HPC). We have shown that cytokine-stimulated hematopoietic cells in reverse produce endothelial growth factors such as vascular endothelial growth factor (VEGF), resulting in a paracrine loop that supports maintenance and proliferation of both, bone marrow endothelium and HPC. 3 Cultivation and expansion of HPC have been proposed as measures to increase the engraftment potential of hematopoietic grafts with insufficient stem cell numbers. 4 In addition, culture methods need to be developed for gene transfer experiments in vitro that are not associated with a stem cell loss. 5 However, incubation of HPC with various cytokine combinations that increase both the total cell number and overall numbers of progenitors (eg CD34 þ cells) is not necessarily associated with expansion of primitive progenitors and putative stem cell candidates such as LTC-IC, CAFC and NOD/SCID-repopulating cells. 6 Coculture of HPC with endothelial cells may offer conditions that are superior to cytokine-supplemented liquid culture. In previous studies, endothelial cells have successfully been used to maintain or increase the number of primitive HPC in vitro. 7 In these experiments, immortalized endothelial cell lines of human origin 8 or xenogeneic endothelial cells (eg porcine brain endothelial cells 9, 10 ) were cultured as feeder layers. However, these promising approaches have not been used yet in the setting of a clinical stem cell transplantation. It is unknown whether cotransplantation of immortalized cell lines or xenogeneic endothelium is associated with the risk of tumorgenesis and immunological effects, particularly in allogeneic stem cell transplantation. In addition, separation of the stem/ progenitor cells from the feeder layer in a direct coculture system may be technically difficult. Therefore, one would prefer the use of primary endothelial cells either from the donor or recipient for in vitro cocultures intended for use as a stem cell graft.
Microvascular endothelium of the hematopoietic tissue has successfully been isolated from bone marrow aspirates (bone marrow endothelial cells, BMEC), 11 but the number of cells obtained is low and a considerable time of in vitro culturing is required to establish a confluent layer. Recipient-derived endothelium might also be obtained from circulating endothelial precursor cells, but the efficacy of this method remains elusive. 12 With regard to autologous HPC, an additional problem in the establishment of expansion cultures is the fact that stem/progenitor cells from the adult (mobilized peripheral blood or bone marrow) are difficult to expand in vitro. HPC from cord blood contain more primitive progenitors and may have a greater expansion potential in vitro. 13, 14 Particularly in allogeneic cord blood transplantation, successful stem cell expansion strategies may be useful to overcome the problem of limited stem cell numbers that prevent a wider application of this stem cell source in transplantation protocols for adults. 14 In addition to HPC, endothelial cells with a high proliferative potential can be obtained from umbilical cords. Indeed, cultivation of human umbilical vein endothelial cells (HUVEC) has emerged as a standard technique in endothelial cell biology, due to the reliable and constant phenotype of the cell population. 15 In contrast to endothelial cells derived from the adult organism, embryonic endothelial cells appear to possess a particular potential to support stem cells maintenance. 16 Endothelium derived from the newborn might also support hematopoiesis more efficiently than endothelium from the adult.
We therefore explored the feasibility of using isolated CD34 þ HPC and HUVEC simultaneously obtained from the same donor in a coculture system. For 3 days, HUVEC cultures were established, meanwhile isolated HPC were maintained in serum-free cytokine-supplemented liquid culture. Coculture with endothelium for an additional week was then compared to continued liquid culture. It is believed that particularly bone marrow endothelium supports hematopoiesis in vitro and in vivo. 8 In contrast to HUVEC and microvascular endothelium of other organs, bone marrow endothelial cells constitutively express inflammatory adhesion molecules such as ICAM-1 and VCAM-1. 17, 18 To mimic this phenotype, small amounts of the inflammatory cytokine interleukin-1 were present in our in vitro cultures in addition to endothelial growth factors. The results of our study demonstrate that this coculture system was superior to liquid culture using in vitro assays for committed and primitive HPC.
Materials and methods

Isolation of cord blood HPC
After obtaining the parents' informed consent in accordance with the guidelines of the Ethical Commitee of the University of Tu¨bingen (project number 33/2000), mononuclear cells (MNC) were separated from cord blood samples by Ficoll density gradient centrifugation. CD34 þ hematopoietic progenitor cells were isolated with immunomagnetic microbeads (MACS system, Miltenyi Biotech, Bergisch Gladbach, Germany).
Isolation and initial culture of umbilical vein endothelial cells (HUVEC)
HUVEC were isolated in parallel with the hematopoietic progenitor cells by collagenase digestion using the standard protocol as described previously. 15 Isolated HUVEC were seeded in 25 cm 2 tissue culture flasks or culture dishes pretreated with gelatine (0.1% in PBS, 10 mg/ml, Biochrom KG, Berlin) and cultivated in endothelial cell medium (ECmedium, Promo Cell, Heidelberg, Germany) containing medium 199, with EGF, basic FGF, hydrocortisone, gentamicin, amphotericin B, 12% FCS and growth supplement.
Cytokine-supplemented liquid culture of HPC and coculture with HUVEC Isolated hematopoietic progenitor cells (1 Â 10 5 ) were cultured for 3 days in 5 ml serum-free medium (X-VIVO 20, BioWhittaker, Walkersville, MD, USA) supplemented either with recombinant human stem cell factor (SCF, 50 ng/mL, Peprotech Inc., Rocky Hill, NJ, USA) or with a combination of cytokines: SCF (50 ng/ml, Peprotech), Flt3-ligand (50 ng/ml, Peprotech), interleukin-6 (IL-6, 10 ng/ml, Tebu, Frankfurt, Germany). At day 3, vascular endothelial growth factor (VEGF 165 , 50 ng/ml, R&D Systems, Wiesbaden, Germany) and interleukin-1 (10 ng/ml, Peprotech) were added and the cells were either transferred onto the endothelial layer or kept in liquid culture for additional 7 days. At the end of the culture period of 10 days, nonadherent and (by trypsination) adherent cells were recovered from cocultures, counted and analyzed. In liquid cultures, all cells could be recovered without trypsination.
Flow cytometry
For FACS analysis, 1-2 Â 10 5 were incubated for 30 min at 41C with the FITC or PE-conjugated monoclonal antibody (mAb) CD34, CD45, CD38, CD41a, CD14, CD15, Glycophorin A (Becton-Dickinson, Heidelberg, Germany). An isotype-identical mAb served as a control. The cells were analyzed using a FACScalibur flow cytometer (Becton-Dickinson). To calculate the percentage of positive cells, a proportion of p1% false positive events was accepted in the negative control sample.
Assay for clonogenic progenitors
Cells were plated in triplicate in 35-mm tissue culture dishes (Greiner, Frickenhausen, Germany) containing 0.9% methycellulose, 30% fetal bovine serum, 1% bovine serum albumine, 70% Iscove's DMEM (Stem Cell Technologies Inc., Vancouver, Canada), and a combination of five cytokines: human SCF (20 ng/ml, Pepro Tech), human interleukin-3 (50 ng/ml,Tebu), interleukin-6 (20 ng/ml, Tebu), human granulocyte colony-stimulating factor (rhumet-G-SCF, 100 ng/ml, Amgen, Thousand Oaks, CA, USA), and human erythropoietin (6 U/ml, Jannsen-Cilag, Neuss, Germany). The plates were cultured for 14 days at 371C, 100% humidity, and 5% CO 2 . Colonies (440 cells) were scored using an inverted microscope. By this technique, erythroid (burst-forming and colony-forming units-erythroid: BFU-E, CFU-E), myeloid colonies (colony-forming units granulocyte, macrophage, and granulocyte-macrophage: CFU-G, CFU-M, CFU-GM) and mixed colonies could be detected.
Assay for long-term culture-initiating cells (LTC-IC) and cobble stone area-forming cells (CAFC)
For determination of LTC-IC, the contact inhibited FBMD-1 murine stromal cell line was used as described before.
19 After 7-10 days of culture at 331C and 10% CO 2 , the stromal layers reached confluency and were overlaid with cord blood CD34 þ HPC or cultured cells within the subsequent week. The stromal cultures were incubated at 371C and 10% CO 2 for 5 weeks with weekly half-medium changes. Adherent and nonadherent cells were then recovered and plated together in a semisolid colony assay as described above. This method only allows to relatively compare the number of LTC-IC contained in different cell populations seeded in parallel on FBMD-1 stroma. To quantitatively determine primitive progenitors, a CAFC assay was used. Confluent stromal layers of FBMD-1 cells grown in flat-bottom 96-well plates were overlaid with HPC or cultured cells in a limiting dilution setup. For CD34 þ HPC, 2048 cells per well were used in the first dilution; for cultured cells, 2048 cells multiplied by the expansion factor of total cells. A total of 12 serial dilutions were used for each sample with 16 replicate wells per dilution. The cells were cultured at 371C and 10% CO 2 for 5 weeks with weekly half-medium changes. The percentage of wells with at least one phase-dark hematopoietic clone of at least five cells (ie, a cobblestone area) beneath the stromal layer was determined with an inverted microscope. Frequencies of total CAFC were calculated using Poisson statistics as described previously. 20 
Statistical analysis
Data from independent experiments were expressed as mean 7s.e.m. (standard error of the mean) of at least three experiments. Differences between groups were compared by Student's t-test and considered significant at Po0.05.
Results
Cell collection and isolation
Collection of cord blood cells was carried out according to methods routinely used in the clinical setting of cord blood transplantation. Furthermore, isolation of CD34 þ cells with immunomagnetic microbeads is a technique already established in autologous and allogeneic transplantation. Thus, only the method of endothelial cell collection is fully experimental and needs to be transferred into the clinical setting before a potential clinical study can be initiated. After collection of the cord blood, the umbilical cord was clamped at its proximal and distal parts, cut off, and stored (including the clamps) in a sterile container at 41C. After transportation to the laboratory, the cord (including the clamps) was fully immersed in an alcoholic disinfectant (as used for surgical procedures), and rinsed with saline under a sterile flow cabinet. Afterwards, the clamps were cut off. The umbilical vein was cannulated at both ends of the cord, and rinsed with PBS. The final step consisted of collagenase instillation and incubation for 10 min at 371C. Owing to the disinfection step consisting of complete immersion, the risk of bacterial contamination of this procedure is low, similar to tissue sampling under aseptic conditions, which will facilitate translation of this method into clinical routine.
Coculture system
After collagenase digestion, endothelial cells were recovered mainly as aggregates and fragments of the umbilical vein endothelial layer, washed, and allowed to adhere in at least four 25 cm 2 tissue culture flasks during overnight incubation (approximately 50 cm 2 growth area per 10 cm cord length, umbilical cord pieces shorter than 20 cm were excluded). Although not performed in this study, the cells can be frozen before culturing, resulting in a recovery 495% after thawing (trypan blue) with unchanged growth characteristics. The following day, medium was exchanged to remove debris, nonadherent cells and remaining erythrocytes. Owing to a high migratory and mitotic activity of the endothelial cells, endothelial cell aggregates rapidly spread out and patches and even larger areas of confluent growth were visible at day 3, dependent on the isolation efficacy. As measured by flow cytometry using specific endothelial markers, these cultures contained 490% endothelial cells. Some contaminating fibroblasts or smooth muscle cells may however be present throughout the culture period, while hematopoietic cells (CD45 þ ) were virtually absent. For the coculture experiments, 1 Â 10 5 isolated CD34 þ cells from the same donor were cultivated in parallel in 5 ml of cytokine supplemented serum-free medium. After 3 days, VEGF and IL-1 were added, and the culture was either continued as liquid culture or cells with medium were transferred to a 25 cm 2 flask containing autologous day 3 HUVEC, after removal of the EC-medium. In areas with patchy growth, progenitor cells tended to adhere to the HUVECs, which reached confluency during several days of further coculture. At 7 days after addition of CD34 þ progenitor cells to HUVECs, (day 10), all cells (nonadherent and adherent) were recovered and further characterized. In Figure 1 , the phase contrast morphologies of a representative coculture and the corresponding liquid culture are shown. Large areas with confluent HUVEC layers were observed in this experiment already at day 3. The density of hematopoietic cells was markedly increased in coculture with endothelium compared to liquid culture alone.
Total cell numbers and CD34 þ HPC in liquid culture and coculture
The total cell number in liquid culture was moderately increased at day 10, approximately three-fold with 3 growth factors and 10-fold with 5 factors compared to day 0. In coculture with HUVEC however, the expansion of total cells was 55-fold with 3 factors and 77-fold with 5 factors (Figure 2 ). Regarding the number of CD34 þ cells, coculture with HUVEC was again superior to liquid culture. CD34 þ cells were maintained in liquid culture with 3 factors, but 15-fold expanded with 3 factors in the presence of endothelium. Liquid cultures supplemented with 5 factors resulted in a three-fold expansion of CD34 þ HPC that was increased to 23-fold in the presence of autologous HUVEC.
Expansion of clonogenic progenitors
In coculture with HUVEC, the number of clonogenic progenitors was more efficiently expanded (19-and 32-fold for 3 and 5 factors) compared to liquid culture alone (Figure 3 ). In contrast, only a four-fold increase in the colony-forming units was observed in the liquid cultures with 5 factors added. All types of erythroid and myeloid colony-forming units were more efficiently expanded when compared to liquid culture alone (Figure 3) . Interestingly, primitive mixed colonies were increased at day 10 compared to day 0 only in the presence of HUVEC and 5 growth factors added. In all other conditions, the number of CFU-mix was either maintained or even reduced. 3F + E 5F 5F + E Figure 1 Morphology (phase contrast, Â 100) of expansion cultures. Liquid culture of CD34 þ hematopoietic progenitor cells supplemented with 3 (3F) or 5 growth factors (5F) was compared to endothelial (E) coculture with autologous HUVEC (3F þ E and 5F þ E). The upper panels show cultures immediately after addition of the progenitor cells at day 3, the lower panels at day 10 (end of culture period). Coculture with endothelium results in massive expansion of the total hematopoietic cell number. HUVEC. In the liquid cultures, all cells were nonadherent. In the cocultures, the adherent (adh.) and nonadherent (nonadh.) total nucleated hematopoietic cells and CD34 þ progenitors were quantified for each experiment separately and then added up to obtain the total number of cells and progenitors (coculture total). Either 3 (3F) or 5 growth factors (5F) were supplemented. The data were expressed as relative expansion (1 ¼ CD34 þ cord blood progenitors before expansion). Coculture with endothelium was superior to liquid culture (**2Po0.01, ***2Po0.001).
However, the overall frequency of CFU-mix was low compared to myeloid or erythroid colony-forming units.
Primitive progenitors (LTC-IC, CAFC) in liquid culture and coculture
In the liquid cultures, there was a slight increase in the number of LTC-IC when calculated relatively from the numbers of colonies generated on FBMD-1 stroma, which was significantly further raised by the presence of endothelium (Figure 4 ). Using the more accurate limiting dilution analysis, the total number of CAFC was calculated for the starting cell population (day 0) as well as for each culture condition at day 10. With liquid culture alone, the number of CAFC at day 10 was two to three-fold reduced compared to day 0 (Figure 4) . Only in coculture with endothelium, maintenance of CAFC could be achieved largely independent of the number of cytokines added. There was only a slight trend towards increased numbers of CAFC in the coculture supplemented with three cytokines, which did not reach statistical significance.
Generation of mature hematopoietic cells in expansion cultures
At day 10, the majority of cells in the expansion culture comprised precursors and more mature hematopoietic cells. Examples of the flow cytometry analysis are shown in Figure 5 ; a quantitative analysis is given in Table 1 . Independent of the presence of endothelial cells, only a small number of erythroid (glycophorin A þ ) and virtually no megakaryocytic (CD41a þ ) cells were observed in the expansion cultures. In contrast, mainly CD14 þ /CD15( þ ) monocytic cells and CD15 þ þ granulocytic precursors could be detected in liquid cultures and cocultures in the presence of endothelial cells. However, a considerable propoprtion of the expanded cells was negative for markers of myeloid, megakaryocytic or erythroid differentiation and may therefore represent undifferentiated progenitors, which were only partially CD34-positive ( Figure 5 ).
Discussion
In this study, we demonstrate the feasibility of coculture systems based on parallel isolation of CD34 þ cord blood progenitor cells and HUVEC from the same umbilical cord. In previous studies, only endothelial cells from other sources including xenogenic cell lines have been used for ex vivo expansion in endothelial coculture systems, which might be less attractive considering a potential use in humans. [7] [8] [9] [10] However, the promising results of those studies have encouraged us to explore the capacity of 'autologous' endothelial cells to support progenitor cell expansion in vitro. In our approach, we added VEGF to maintain endothelial integrity in the cultures and IL-1 to mimic a bone marrow endothelial phenotype. 17 This strategy is based on the assumption that bone marrow endothelium more efficiently supports hematopoietic progenitor cell maintenance than endothelium from other tissues. 8 Indeed, without addition of these factors, both maintenance of the endothelium and progenitor cell expansion was not possible. It was an interesting and potential clinically relevant observation that establishment of endothelial layers and consecutive coculture of isolated CD34 þ progenitor cells could be performed without the need of temporary cryoconservation. In the allogeneic setting, it might be more suitable to cryopreserve hematopoietic and endothelial cells separately and establish the expansion culture prior to transplantation. On the other hand, cord blood progenitor cells are increasingly collected 21 by private cord blood banks at the parents' expense not only for allogeneic, but also for potential autologous use. Indeed, first reports of successful autologous cord blood transplantations have been published. 22 For these purposes, upfront expansion followed by cryopreservation represents a realistic perspective to overcome the limited progenitor cell number in a single graft. Also to minimize interexperimental variations in our proof-of-principle approach, we did not include freezing and thawing procedures. In our system, the endothelial coculture was superior to liquid culture in all conditions tested, including in vitro assays for Before cult. 5F
Before cult. 3F Liquid cult. 5F Liquid cult. 3F
Cocult. nonadh. 5F Cocult. nonadh. 3F Cocult. adh. 5F Cocult. adh. 3F Cocult. total 5F C ocult. total 3F total cell numbers, committed and more primitive progenitor cells. The endothelial cultures directly grown from the cells isolated by collagenase treatment without passaging ('passage 0') may contain up to several percent nonendothelial cells (eg, fibroblasts, smooth muscle cells). A completely pure, homogeneous HUVEC culture would require several weeks of cultivation, including passaging. As supported by our data, however, the purity of the feeder layer can be neglected, as long as the vast majority of the coculture, added to FBMD-1 stromal layers and incubated for 5 weeks. The total number of colonies grown from stroma-adherent and nonadherent cells was then enumerated, and the relative expansion was calculated (1 ¼ CD34 þ cord blood progenitors before expansion). There was a statistically significant advantage when coculture was compared to liquid culture (5 factors supplemented). Right panel: Limiting dilution analysis allowed to calculate the absolute number of CAFC in the starting population (1 Â 10 5 CD34 þ cells) and after expansion with and without autologous HUVEC. The analysis revealed that CAFC were maintained only in coculture, while a significant loss of primitive progenitors was detected after 10 days of liquid culture. 
CD41a and glycophorin-A (GlyA) expression was assessed at day 10 (representative samples of cocultured cells are shown). A significant proportion of the cells were CD14 þ /CD15 þ þ (mature myeloid) and CD14 þ /CD15 þ (mature monocytic), while only few GlyA þ (erythroid) and virtually no CD41a (megakaryocytic) cells were detected. A quantitative summary is given in Table 1. population consists of endothelial cells. Further passaging rather changes the endothelial phenotype and would create additional problems in a potential clinical setting. As described in the results section, our method including the preparation steps is suitable for immediate transfer into clinical use. For this purpose, only certification of the reagents/media or optimizing for already certified components would be required. It is still an open question whether primitive hematopoietic progenitors including putative stem cells can be expanded in cytokine-supplemented liquid culture. If at all, cord blood progenitor and stem cells may possess an expansion potential in liquid culture ex vivo, in contrast to bone marrow-or mobilized blood-derived stem cells. 13 Also coculture with stromal cells is not necessarily associated with an expansion of more primitive progenitors. 23 However, the fact that coculture systems with endothelial cells have been used in several studies to successfully expand also more primitive progenitors, suggests a specific advantage of this cell type when used as feeder layer in coculture systems. [7] [8] [9] [10] 16 In our study, which aimed at the feasability of an 'autologous' coculture system, the cytokine supplementation was not optimized for a potential use of the expanded cells in a transplantation setting. Therefore, we did not include extensive transplantation studies, which might prove advantageous to ex vivo expansion only when optimal culture conditions are chosen. Further studies with optimized cytokine combinations and culture conditions (eg bioreactor) are required as a basis for a clinical application of the concept of an autologous endothelial coculture system in cord blood transplantation. Whether a growth area of 100 cm 2 (as chosen in our present approach) is suitable for expansion of a whole cord blood graft, remains to be analyzed. However, given the high proliferative capacity of HUVEC, only a few additional days of further culturing, also after addition of hematopoietic progenitor cells, would result in confluent layers of several hundred cm 2 . Previous studies provided explanations why coculture with endothelial cells might be advantageous for progenitor cell expansion. Endothelial cells are capable to produce hematopoietic growth factors such as GM-CSF and G-CSF that support maintenance and expansion of hematopoietic progenitor cells. 24 Also factors other than cytokines derived from endothelial cells support growth of primitive progenitors, as shown for the insulin-like growth factor binding protein-3 (IGFBP-3), a protein that may influence progenitor proliferation by binding IGF or by other mechanisms. 16 In addition, local presentation of membrane-bound factors such as kit-ligand (stem cell factor) particularly by HUVEC 25 may further support the growth of immature hematopoietic cells. We have shown that in reverse, maintenance of endothelial cells in such coculture systems can be achieved by the presence of hematopoietic cells that provide endothelial growth factors such as VEGF. 26 Contact of primitive progenitors to specific cell surface molecules such as lectin-like antigens, which do not belong to any growth factor family may also contribute to their maintenance, as suggested by persistence of primitive progenitors with the potential to hematopoietic repopulation in cultures containing plant lectins.
27 However, other studies suggested that mainly soluble factors contribute to the stem cell-supporting effect observed in progenitor/endothelial coculture systems. 28 Of note, a major proportion of the hematopoietic cells in our expansion cultures did not coexpress markers of terminal myeloid (CD14, CD15), erythroid (glycophorin-A) or megakaryocytic (CD41a) differentiation and therefore corresponds to hematopoietic progenitor and precursor cells. Among the more differentiated cells, particularly myeloid (CD14 þ and CD15 þ ) monocytic and granulocytic cells were found.
It is uncertain whether lineage-determined precursor cells ('post-progenitor cells' particularly of the granulocytic lineage) have the capability to terminally differentiate when transplanted and thus to shorten the duration of neutropenia, which remaines a major problem in autologous and allogeneic stem cell transplantation. 29 A clinical study appeared to demonstrate some clinical benefit in breast cancer patients showing a more rapid neutrophil recovery when ex vivo expanded peripheral blood progenitor cells were transplanted compared to a historical control with unmanipulated grafts. 30 In contrast, umbilical cord blood cells expanded ex vivo with PIXI321, Flt-3 ligand and The percentage of progenitor-associated (CD34+), megakaryocytic (CD41a+), erythroid (GlyA+) and myeloid (CD14+, CD15+, CD15++) antigens was assessed by flow cytometry on day 10 of liquid culture or coculture. There were considerable CD14+, CD15+ and CD15++ subpopulations, while only few cells expressed glycophorin A. CD41a was virtually absent on the expanded cells.
erythropoietin in serum-containing medium failed to result in improved myeloid, erythroid, or platelet recovery in a clinical phase 1 trial. 31 The use of a coculture system that provides a variety of hematopoietic growth factors might overcome the problem that only a limited repertoire of cytokines is available for clinical use in a liquid culture expansion system, which could explain the disappointing results of these studies.
In conclusion, the use of 'autologous' endothelial cells derived from the same umbilical cord offers an attractive approach for ex vivo-expansion of cord blood progenitors, which appears to be superior to cytokine-supplemented liquid culture alone. Our findings provide the rationale for further studies that involve clinically applicable in vitro cultures such as bioreactor systems, optimized, clinically approved cytokine supplementation, and in vivo engraftment studies. 
